Overview
Updated 14 Jul 2026
Matthew J. Frigault, MD, is Assistant Professor of Medicine, Harvard Medical School at Massachusetts General Hospital / Mass General Brigham. The public record shows 302 publications with 12,739 citations (h-index 48), centered on Leukemia (AML/ALL/CML/CLL), Lymphoma, Multiple Myeloma. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 19 companies.
- Most recent indexed publication: 2026 · Blood
- Top research focus: Leukemia (AML/ALL/CML/CLL)
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Emapalumab Prevention of CAR-T Cell Associated Toxicities
Sponsor: Marcela V. Maus, M.D.,Ph.D.
InvestigatorPhase 2RecruitingNCT06550141 - CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Sponsor: Marcela V. Maus, M.D.,Ph.D.
InvestigatorPhase 1RecruitingNCT06026319
Industry payments
Updated 14 Jul 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20251 payment
- Legend Biotech USA Inc.Program year20251 payment
- Gilead Sciences, Inc.Program year20251 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Stealth transgenes enable CAR-T cells to evade host immune responses.
Journal for immunotherapy of cancer
2024
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
32 Fruit Street, Yawkey Building, 9th Floor, Suite 9A, Boston, MA 02114
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- BA
College of the Holy Cross, magna cum laude
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
Editorial & leadership rolesjournal and society appointments
- Clinical Director
Cellular Immunotherapy Program, Mass General Cancer Center (BMT & Cellular Therapy)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Medical Oncologist
Hematologic Malignancy Program, Massachusetts General Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
Awards & honorshonors on the public record
- Inaugural John and Ashley Ranelli Endowed Scholar in Cancer Innovation
Massachusetts General Hospital ($1M endowed scholar position)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giving.massgeneral.org ↗
Secondary affiliationsappointments beyond the home institution
- Member
Dana-Farber/Harvard Cancer Center (DF/HCC) Leukemia Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dfhcc.harvard.edu ↗ - Advisory Board
ImmunoFree
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →immunofree.com ↗
Media & interviewspress, podcasts and appearances
- OncLive video interview series on CAR T-cell therapy in leukemia
lymphoma, and multiple myeloma (multiple appearances, incl. "Dr. Frigault on Toxicity Differences Among CAR T-Cell Products in Leukemias, Lymphomas")
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - "Updates in CAR T-Cell Therapy"
Mass General Advances in Motion video interview with Billy Costa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/matthew-frigault-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Facebook
facebook.com/MassGeneralBrigham/posts/matthew-frigault-md-inaugural-incumbent-of-the-john-and-ashley-ranelli-endowed-s/1160173909485228
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/p/DMdrkAVzp0u
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/posts/mass-general-brigham_matthew-frigault-md-inaugural-incumbent-activity-7353884159007694848-cMhH
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Roy Perlis, MD
Mass General Brigham
- 908
- publications
- 105
- h-index
- 5
- trials
Janet Wozniak, MD
Mass General Brigham
- 233
- publications
- 60
- h-index
- 12
- trials
Michael Boland, MD
Mass General Brigham
- 283
- publications
- 39
- h-index
- 1
- trial